HFCWOis a based guideline nonpharmacologic airway clearance therapy, grouped with other oscillatory devices (flutter, intrapulmonary percussive ventilation) that aim to enhance mucus clearance by applying high-frequency oscillations through the chest wall, causing the airways to vibrate and mobilizing secretions.
Oscillations can be delivered either through the mouth or through the chest wall, causing the airways to vibrate and thereby mobilizing pulmonary secretions.
HFCWO can be performed with the patient seated or supine.
The technique has been referred to as either high-frequency chest compression or high-frequency chest wall oscillation.
HFCWO/vest therapy is a mechanical airway clearance technique in which an inflatable vest covering the thorax is connected to an air-pulse generator that rapidly inflates and deflates, transmitting oscillatory compressions through the chest wall to the airways.
It is widely used because it can be self-administered and is less labor-intensive than conventional chest physiotherapy, with studies suggesting it is at least as effective as conventional methods for clearing bronchial secretions, particularly in cystic fibrosis.
Proposed mechanisms of action: Expiratory flow bias — producing a cough-like, high-velocity expiratory airflow that shears mucus from airway walls and propels it cephalad when expiratory flow exceeds inspiratory peak flow.
Altered mucus rheology — reducing viscosity, spinnability, and viscoelasticity of secretions.
Increases ciliary beat frequency via vagal stimulation, especially at oscillation frequencies around 11–15 Hz.
Oscillation frequencies are selectable, generally in the range of 5–20 Hz (commonly 10–15 Hz), with pressures up to roughly 50 cmH₂O; sessions typically run 10–20 minutes, one to three times daily.
Clinical uses: HFCWO is used in conditions with impaired mucociliary clearance or weak cough, including cystic fibrosis, bronchiectasis, primary ciliary dyskinesia, neuromuscular disease, and severe global developmental delay/cerebral palsy.
Emerging ICU data suggest HFCWO may improve lung aeration and oxygenation in hypersecretive mechanically ventilated patients compared with conventional physiotherapy.
Despite a plausible physiological rationale, direct proof of the mechanism and high-quality comparative efficacy data remain limited, particularly in neuromuscular populations.
High frequency chest wall oscillation (HFCWO) is an airway clearance therapy that uses an inflatable vest connected to an air-pulse generator.
The vest rapidly squeezes and releases the chest (typically 5-25 Hz), which vibrates the chest wall, thins mucus, and helps move secretions toward the larger airways where they can be coughed up.
Commonly used:
Cystic fibrosis Bronchiectasis Neuromuscular disease (ALS, muscular dystrophy, spinal cord injury) where cough is weak Chronic lung conditions with heavy mucus
Sessions of roughly 10-30 minutes, once or twice daily, with frequency and pressure set by a clinician
Often paired with a bronchodilator or nebulized medication beforehand
Coughing or huffing breaks during the session help clear loosened mucus
Generally avoided or used carefully with unstable head/neck injury, recent chest or abdominal surgery, active bleeding or hemoptysis, pneumothorax, rib fractures, or severe osteoporosis.
Often considered equivalent to other airway clearance methods (manual physiotherapy, PEP devices) rather than clearly superior